BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21123941)

  • 1. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas.
    Rezvani HR; Kim AL; Rossignol R; Ali N; Daly M; Mahfouf W; Bellance N; Taïeb A; de Verneuil H; Mazurier F; Bickers DR
    J Clin Invest; 2011 Jan; 121(1):195-211. PubMed ID: 21123941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species.
    Rezvani HR; Rossignol R; Ali N; Benard G; Tang X; Yang HS; Jouary T; de Verneuil H; Taïeb A; Kim AL; Mazurier F
    Biochim Biophys Acta; 2011 Jun; 1807(6):609-19. PubMed ID: 21167810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN positively regulates UVB-induced DNA damage repair.
    Ming M; Feng L; Shea CR; Soltani K; Zhao B; Han W; Smart RC; Trempus CS; He YY
    Cancer Res; 2011 Aug; 71(15):5287-95. PubMed ID: 21771908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xeroderma pigmentosum: a useful model to study the relation between genomic mutations and cell transformation].
    Rezvani HR; Taïeb A
    Med Sci (Paris); 2011 May; 27(5):467-70. PubMed ID: 21609663
    [No Abstract]   [Full Text] [Related]  

  • 5. The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas.
    de Feraudy S; Ridd K; Richards LM; Kwok PY; Revet I; Oh D; Feeney L; Cleaver JE
    Am J Pathol; 2010 Aug; 177(2):555-62. PubMed ID: 20616346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New functions of XPC in the protection of human skin cells from oxidative damage.
    D'Errico M; Parlanti E; Teson M; de Jesus BM; Degan P; Calcagnile A; Jaruga P; Bjørås M; Crescenzi M; Pedrini AM; Egly JM; Zambruno G; Stefanini M; Dizdaroglu M; Dogliotti E
    EMBO J; 2006 Sep; 25(18):4305-15. PubMed ID: 16957781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature skin aging features rescued by inhibition of NADPH oxidase activity in XPC-deficient mice.
    Hosseini M; Mahfouf W; Serrano-Sanchez M; Raad H; Harfouche G; Bonneu M; Claverol S; Mazurier F; Rossignol R; Taieb A; Rezvani HR
    J Invest Dermatol; 2015 Apr; 135(4):1108-1118. PubMed ID: 25437426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The XPC poly-AT polymorphism in non-melanoma skin cancer.
    Nelson HH; Christensen B; Karagas MR
    Cancer Lett; 2005 May; 222(2):205-9. PubMed ID: 15863269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C.
    Ming M; Shea CR; Guo X; Li X; Soltani K; Han W; He YY
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22623-8. PubMed ID: 21149730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective DNA damage responses in murine Xpa-/-, Xpc-/- and Csb-/- keratinocyte cultures.
    Stout GJ; Oosten Mv; Acherrat FZ; Wit Jd; Vermeij WP; Mullenders LH; Gruijl FR; Backendorf C
    DNA Repair (Amst); 2005 Nov; 4(11):1337-44. PubMed ID: 16182614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing roles for calcineurin and ATF3 in squamous skin cancer.
    Wu X; Nguyen BC; Dziunycz P; Chang S; Brooks Y; Lefort K; Hofbauer GF; Dotto GP
    Nature; 2010 May; 465(7296):368-72. PubMed ID: 20485437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis.
    Ananthaswamy HN; Ouhtit A; Evans RL; Gorny A; Khaskina P; Sands AT; Conti CJ
    Oncogene; 1999 Dec; 18(51):7395-8. PubMed ID: 10602497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation.
    Liu L; Rezvani HR; Back JH; Hosseini M; Tang X; Zhu Y; Mahfouf W; Raad H; Ragi G; Athar M; Kim AL; Bickers DR
    PLoS One; 2014; 9(5):e97245. PubMed ID: 24824222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of XPC leads to a shift between respiratory complexes I and II but sensitizes cells to mitochondrial stress.
    Mori MP; Costa RA; Soltys DT; Freire TS; Rossato FA; Amigo I; Kowaltowski AJ; Vercesi AE; de Souza-Pinto NC
    Sci Rep; 2017 Mar; 7(1):155. PubMed ID: 28273955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.
    Yang G; Curley D; Bosenberg MW; Tsao H
    Cancer Res; 2007 Jun; 67(12):5649-57. PubMed ID: 17575131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular carcinogenesis of squamous cell carcinomas of the skin.
    Kubo Y; Murao K; Matsumoto K; Arase S
    J Med Invest; 2002 Aug; 49(3-4):111-7. PubMed ID: 12322999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells.
    Chen JC; Ko JC; Taso YC; Cheng HH; Chen TY; Yen TC; Lin YW
    Pharmacology; 2021; 106(3-4):154-168. PubMed ID: 33202406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of Akt-induced keratinocyte transformation.
    Segrelles C; Moral M; Lara MF; Ruiz S; Santos M; Leis H; García-Escudero R; Martínez-Cruz AB; Martínez-Palacio J; Hernández P; Ballestín C; Paramio JM
    Oncogene; 2006 Feb; 25(8):1174-85. PubMed ID: 16247457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.